Skip to content

End of Appointment

The duration of the research appointment is specified in the appointment letter (and any subsequent extension letters) that a participant receives from ORISE. Appointment end dates must be strictly observed and may not be changed without the appropriate communication from ORISE.

As a participant’s scheduled end date approaches, ORISE will send a letter confirming the end date and outlining the procedures necessary to complete the appointment. The participant will need to submit a final report (one to two pages in length) describing the research and educational experiences during the appointment and evaluating the assistance provided by FDA and ORISE. Any outstanding travel reimbursement forms must also be submitted. These items must be received by ORISE before the final stipend can be issued.

Participants who are enrolled in the ORISE insurance plan will receive a COBRA election form detailing the options for continuing their coverage.

Leaving an Appointment Early

Should a participant need to leave the program before the end of the appointment, the participant should directly inform his/her ORISE point of contact, mentor and program coordinator. Two weeks’ notice is requested. Providing insufficient notice, or failure to communicate directly with ORISE, could result in unnecessary complications with final stipend payments.

Extending an Appointment

Continuing participation after the end of the appointment, even by a single day, is not permitted without first receiving an appointment extension. Please see Renewal of Appointment for more information on this process.